Research

Research Library

This page exists to keep EVY’s public messaging honest. We separate peer-reviewed work from company-reported outcomes and link to the source material.

General wellness positioning

EVY is intended as a general wellness experience and is not intended to diagnose, treat, cure, or prevent disease.

Source-first policy

If a claim cannot be traced to a source, it does not ship. If a number is company-reported, we label it as such.

Evolving evidence

Research changes. We treat this library as a living document and update it as higher-quality sources become available.

Sources

Linked references

These links are provided for transparency and review. They do not constitute medical advice.

Back to home
Cognito Therapeutics — Clinical Studies (OVERTURE / HOPE)
Company site • Cognito Therapeutics
Open source

Primary starting point for Cognito’s study descriptions and reported outcomes. Treat as company-reported unless linked to peer-reviewed publications.

Cognito Therapeutics Announces Positive Phase 2 Results (company-reported outcomes)
Press release • Business Wire
Open source

Press release summarizing Phase 2 reported outcomes. Not a substitute for peer-reviewed publication; included for transparency about commonly cited figures.

MIT Technology Licensing Office — FY2024 Annual Report (Cognito highlight)
Institutional report • MIT TLO
Open source

Institutional summary referencing Cognito’s reported results in context of MIT-licensed technology.

© 2025 Optoceutics. EVY Platform — EVY = Life.
Claims regarding the effectiveness of EVY are based on ongoing research and have not been conclusively proven. EVY is intended as a general wellness product and is not intended to diagnose, treat, cure, or prevent any disease or medical condition.